Table of Contents
1. EXECUTIVE SUMMARY
Scope and Methodology
- Scope and Segmentation
- Methodology
Industry Overview
- An Overview of AntiCancer Therapeutics Industry
- Key Findings
2. TECHNOLOGY TREND AND ADOPTION FACTOR ANALYSIS
Technology Trends in Cancer Therapies
- Emerging Trends in Anticancer Therapeutic Approaches-- Diagnostics;
Therapeutics; and Drug Delivery
- Analysis of Potential Opportunities for Cancer Research
Strategic Analysis and Recommendations
- Growth Accelerating Factors for Anticancer Drug Therapies
- Growth Restraining Factors for Anticancer Therapies
- Strategic Recommendations
- Technologies Impacting Future of Cancer Therapy
- Cancer Research Funding Sources
- Corporate Mergers and Acquisitions
3. GLOBAL DEVELOPMENTS IN CANCER THERAPIES
Noteworthy Developments in Corporate Sector
- Kinase Inhibiing Oral Drug to Treat GIST and Renal Cell Carcinoma
- VEGF Inhibitor Drug Effectively Treats Metastatic Breast Cancer
- Dual Action Heparan Sulphate Mimetic for Hepatocellular Carcinoma
- Unique Technology with Multiple Applications for Cancer Diagnosis and
Therapy
- Next Generation Small Molecule Drug for Peripheral T-cell Lymphomas
- Cancer Killing Virus Technology to Treat Metastatic Melanoma
- Automated FISH Technology for Cancer Diagnosis
- Novel Technology that Overcomes Immune Tolerance to Self Antigens in
Cancer and Immunological Diseases
- Novel Technology Platform for Discovery of Novel Class of Cancer
Therapeutics
- Ground Breaking Liposomal Drug Delivery Technology for Cancer Therapy
- Disease Specific Microarray for the Development of Diagnostic and
prognostic Tests for Cancer
- Novel Therapy to Treat Malignant Glioma
- DNA Interference Drug to Treat Cancer and Genetic Diseases
- Personalized Cancer Diagnostic Test Aids the Selection of Chemotherapeutic
Drugs
Noteworthy Developments in Academia
- Discovery of Telomerase Related Proteins Raises Hopes of Antitumor Therapy
- Nanoworms Enable Tumor Targeting and Diagnostic Imaging of Cancers
4. INTELLECTUAL PROPERTY SCENARIO AND KEY INDUSTRY PARTICIPANTS
Patent Details
- Corporate Sector
- Academic Sector
Contact Details
- Industry Participants
- University and Academia
5. DECISION SUPPORT DATABASE
Decision Support Tables
- Number of Biotech Companies (2002 to 2012)
- Venture Capital Investment in Biotechnology (2002 to 2012)
- Incidence of Breast Cancer (2002 to 2012)
- Incidence of Prostate Cancer (2002 to 2012)
- Incidence of Bladder Cancer (2002 to 2012)
- Incidence of Liver Cancer (2002 to 2012)
|
Related Report
|
View Cart
